NCT04570540

Brief Summary

This study focuses on a comprehensive examination of obese patients with sleep-related breathing disorders including patients with OSA, sleep hypoventilation and OHS. The aim of this study is to (1) evaluate characteristics of and differences between severity levels of obesity-related breathing disorders, (2) discuss pathophysiological variables associated with hypoventilation during sleep or at daytime and (3) find functional parameters indicating sleep hypoventilation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 24, 2014

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2019

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 25, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 30, 2020

Completed
Last Updated

September 30, 2020

Status Verified

September 1, 2020

Enrollment Period

5.4 years

First QC Date

September 25, 2020

Last Update Submit

September 29, 2020

Conditions

Keywords

Obstructive Sleep ApneaSleep Hypoventilation

Outcome Measures

Primary Outcomes (1)

  • Hypercapnic ventilatory response

    Within 48 hours of sleep lab admission

Study Arms (3)

OSA

Obstructive Sleep Apnea as confirmed by full-night attended in-lab polysomnography showing an apnea-hypopnea index of \>=15 per hour or, alternatively, an apnea-hypopnea index \>=5 with excessive daytime sleepiness as defined by an Epworth Sleepiness Scale score \>9.

Diagnostic Test: Sleep StudyDiagnostic Test: Pulmonary Function TestDiagnostic Test: Hypercapnic ventilatory responseDiagnostic Test: Cardiopulmonary Exercise Test

OSA+SH

Obstructive Sleep Apnea as confirmed by full-night attended in-lab polysomnography showing an apnea-hypopnea index of \>=15 per hour or, alternatively, an apnea-hypopnea index \>=5 with excessive daytime sleepiness as defined by an Epworth Sleepiness Scale score \>9. Furthermore, co-existing hypoventilation during sleep, defined by the presence of intermittent hypercapnia as measured by transcutaneous capnometry and arterialized capillary blood gas analysis.

Diagnostic Test: Sleep StudyDiagnostic Test: Pulmonary Function TestDiagnostic Test: Hypercapnic ventilatory responseDiagnostic Test: Cardiopulmonary Exercise Test

OHS

Obstructive Sleep Apnea as confirmed by full-night attended in-lab polysomnography showing an apnea-hypopnea index of \>=15 per hour or, alternatively, an apnea-hypopnea index \>=5 with excessive daytime sleepiness as defined by an Epworth Sleepiness Scale score \>9. Furthermore, co-existing hypoventilation during wakefulness, defined by a PCO2\>45mmHg as measured by arterialized capillary blood gas analysis.

Diagnostic Test: Sleep StudyDiagnostic Test: Pulmonary Function TestDiagnostic Test: Hypercapnic ventilatory responseDiagnostic Test: Cardiopulmonary Exercise Test

Interventions

Sleep StudyDIAGNOSTIC_TEST

Full-night attended in-lab polysomnography with accompanying transcutaneous capnometry

OHSOSAOSA+SH

Bodyplethysmographic assessment

OHSOSAOSA+SH

Measurement of hypercapnic ventilatory response based on the method described by Read in 1967, using a rebreathing bag

OHSOSAOSA+SH

Symptom-limited cardiopulmonary exercise test with a ramp protocol according to the ATS/ACCP and ERS recommendations

OHSOSAOSA+SH

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Obese patient routinely admitted to sleep lab

You may qualify if:

  • Age ≥18 years
  • BMI ≥ 30 kg/m²
  • Indication for sleep lab admission or indication for BiLevel or non-invasive ventilation therapy initiation due to existing hypoventilation/OHS

You may not qualify if:

  • Age \<18 years
  • Pregnancy, Lactation
  • Any medical, psychological or other condition impairing the patient's ability to provide informed consent.
  • Missing informed consent
  • Participation in another clinical study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V.

Solingen, North Rhine-Westphalia, 42699, Germany

Location

Related Publications (1)

  • Herkenrath SD, Treml M, Hagmeyer L, Matthes S, Randerath WJ. Severity stages of obesity-related breathing disorders - a cross-sectional cohort study. Sleep Med. 2022 Feb;90:9-16. doi: 10.1016/j.sleep.2021.12.015. Epub 2022 Jan 4.

MeSH Terms

Conditions

Obesity Hypoventilation SyndromeSleep Apnea, Obstructive

Interventions

PolysomnographyRespiratory Function TestsExercise Test

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesHypoventilationRespiratory InsufficiencySleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Monitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Respiratory SystemHeart Function TestsDiagnostic Techniques, CardiovascularErgometryInvestigative Techniques

Study Officials

  • Winfried J Randerath, Prof. Dr.

    Chief Physician

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2020

First Posted

September 30, 2020

Study Start

April 24, 2014

Primary Completion

September 10, 2019

Study Completion

September 10, 2019

Last Updated

September 30, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations